Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment Refractory”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchLooking for participantsNCT07048353
What this trial is testing

CD30 CAR-T in the Treatment of CD30 Positive Lymphoma

Who this might be right for
LymphomaB Cell LymphomaCD30+ Peripheral T-cell Lymphoma
Shandong Qilu Cell Therapy Engineering Technology Co., Ltd 15
Testing effectiveness (Phase 2)Study completedNCT00425672
What this trial is testing

ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment

Who this might be right for
Male Breast CancerRecurrent Breast CancerStage IIIA Breast Cancer+3 more
University of Washington 15
Not applicableStudy completedNCT04352569
What this trial is testing

Efficacy of tDCS in the Treatment of Resistant Auditory Hallucinations in Schizophrenia

Who this might be right for
SchizophreniaHallucinationsRefractory Schizophrenia
Centre hospitalier de Ville-Evrard, France 25
Very early researchWithdrawnNCT07338357
What this trial is testing

Clinical Study of CLL-1 CAR-T in the Treatment of Children With R/R AML

Who this might be right for
AML (Acute Myeloid Leukemia)CAR-T
First Affiliated Hospital of Guangxi Medical University
Early research (Phase 1)WithdrawnNCT06411301
What this trial is testing

A Phase I Study to Assess the Tolerability of 225Ac-DOTATATE in Patients With Refractory and Relapsing Multiple Myeloma Expressing Somatostatin Receptors

Who this might be right for
Multiple Myeloma, RefractoryMultiple Myeloma in RelapseMultiple Myeloma Progression
Jules Bordet Institute
Testing effectiveness (Phase 2)Ended earlyNCT00112723
What this trial is testing

Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma

Who this might be right for
Adult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin Lymphoma+25 more
National Cancer Institute (NCI) 46
Not applicableLooking for participantsNCT06812923
What this trial is testing

TACS on High-inflammatory and Refractory Depression

Who this might be right for
Treatment Resistant Depression (TRD)Inflammation
Tianjin Anding Hospital 52
Early research (Phase 1)WithdrawnNCT04770051
What this trial is testing

Percutaneous Inferior Cervical Sympathetic Block for Treatment of Refractory Ventricular Tachycardia

Who this might be right for
Ventricular Tachycardia
University of Missouri-Columbia
Testing effectiveness (Phase 2)Study completedNCT03800602
What this trial is testing

Nivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal Cancer

Who this might be right for
Colorectal AdenocarcinomaMetastatic Microsatellite Stable Colorectal CarcinomaRefractory Colorectal Carcinoma+5 more
Emory University 29
Testing effectiveness (Phase 2)Study completedNCT00054145
What this trial is testing

Perifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
University Health Network, Toronto
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06573151
What this trial is testing

Selinexor, Anti-PD-1 Antibody and P-GemOx Regimen in R/R NKTCL

Who this might be right for
Lymphoma
Ruijin Hospital 28
Early research (Phase 1)Ended earlyNCT04250051
What this trial is testing

Ivosidenib and Combination Chemotherapy for the Treatment of IDH1 Mutant Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Recurrent Acute Myeloid LeukemiaRecurrent Myelodysplastic SyndromeRecurrent Myeloproliferative Neoplasm+5 more
Northwestern University 2
Not applicableLooking for participantsNCT04491929
What this trial is testing

Selective Internal Radiation Therapy With 90Y Resin Micropheres for Refractory Colorectal Cancer Liver Metastases

Who this might be right for
Liver Metastasis Colon Cancer
Aarhus University Hospital 30
Early research (Phase 1)Active Not RecruitingNCT03434769
What this trial is testing

AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma
Benjamin Tomlinson 31
Very early researchUnknownNCT05099094
What this trial is testing

VEGFA-targeting Gene Therapy to Treat Retinal and Choroidal Neovascularization Diseases

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
Shanghai BDgene Co., Ltd. 3
Testing effectiveness (Phase 2)UnknownNCT02060656
What this trial is testing

Phase II Study Comparing LR-GEM to R-GEM-P in Second-line Treatment of Diffuse Large B-cell Lymphoma (LEGEND)

Who this might be right for
Diffuse Large B-Cell Lymphoma
Royal Marsden NHS Foundation Trust 92
Testing effectiveness (Phase 2)UnknownNCT04913922
What this trial is testing

Relatlimab With Nivolumab and 5-Azacytidine for the Treatment of AML

Who this might be right for
Acute Myeloid Leukemia
Ludwig-Maximilians - University of Munich 30
Very early researchUnknownNCT05239702
What this trial is testing

Clinical Study of Targeting CD7 CAR-T Cells in the Treatment of Autoimmune Diseases

Who this might be right for
Crohn DiseaseUlcerative ColitisDermatomyositis+2 more
Zhejiang University 75
Not applicableActive Not RecruitingNCT07155369
What this trial is testing

UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusSystemic Sclerosis
The Affiliated Hospital of Xuzhou Medical University 18
Post-approval studies (Phase 4)UnknownNCT00335205
What this trial is testing

A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression.

Who this might be right for
Bipolar DisorderMajor Depressive Disorder
Sheba Medical Center 60
Next Page